|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | |
| A61K 38/17 | |||
| A61K 38/46 | |||
| A61P 27/02 | |||
| C07K 14/47 |
| (11) | Number of the document | 2872183 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13816245.8 |
| Date of filing the European patent application | 2013-01-23 | |
| (97) | Date of publication of the European application | 2015-05-20 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/022628 |
| Date | 2013-01-23 |
| (87) | Number | WO 2014/011210 |
| Date | 2014-01-16 |
| (30) | Number | Date | Country code |
| 201261670355 P | 2012-07-11 | US |
| (72) |
BELTRAN, William, A., US
AGUIRRE, Gustavo, D., US
JACOBSON, Samuel, G., US
CIDECIYAN, Artur, V., US
LEWIN, Alfred, S., US
BOYE, Sanford, L., US
HAUSWIRTH, William, W., US
DENG, Wen-Tao, US
|
| (73) |
The Trustees of The University of Pennsylvania,
3160 Chestnut Street Suite 200, Philadelphia, PA 19104,
US
University of Florida Research Foundation, Inc., 223 Grinter Hall, Gainesville, FL 32611, US |
| (54) | AAV-MEDIATED GENE THERAPY FOR RPGR X-LINKED RETINAL DEGENERATION |
| AAV-MEDIATED GENE THERAPY FOR RPGR X-LINKED RETINAL DEGENERATION |